160 related articles for article (PubMed ID: 2386372)
1. Pharmacokinetics of amikacin in serum and in tissue contiguous with pressure sores in humans with spinal cord injury.
Segal JL; Brunnemann SR; Eltorai IM
Antimicrob Agents Chemother; 1990 Jul; 34(7):1422-8. PubMed ID: 2386372
[TBL] [Abstract][Full Text] [Related]
2. Amikacin serum protein binding in spinal cord injury.
Brunnemann SR; Segal JL
Life Sci; 1991; 49(2):PL1-5. PubMed ID: 2062169
[TBL] [Abstract][Full Text] [Related]
3. Amikacin pharmacokinetics in patients with spinal cord injury.
Segal JL; Brunnemann SR; Gordon SK; Eltorai IM
Pharmacotherapy; 1988; 8(2):79-81. PubMed ID: 3399423
[TBL] [Abstract][Full Text] [Related]
4. A pilot study evaluating protein abundance in pressure ulcer fluid from people with and without spinal cord injury.
Edsberg LE; Wyffels JT; Ogrin R; Craven BC; Houghton P
J Spinal Cord Med; 2015 Jul; 38(4):456-67. PubMed ID: 24968005
[TBL] [Abstract][Full Text] [Related]
5. Pressure sores and blood and serum dysmetabolism in spinal cord injury patients.
Scivoletto G; Fuoco U; Morganti B; Cosentino E; Molinari M
Spinal Cord; 2004 Aug; 42(8):473-6. PubMed ID: 15111999
[TBL] [Abstract][Full Text] [Related]
6. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
Lugo G; Castañeda-Hernández G
Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of pressure sores in acute spinal cord injuries.
Richardson RR; Meyer PR
Paraplegia; 1981; 19(4):235-47. PubMed ID: 7290733
[TBL] [Abstract][Full Text] [Related]
8. Skin sores after spinal cord injury: relationship to life adjustment.
Krause JS
Spinal Cord; 1998 Jan; 36(1):51-6. PubMed ID: 9471139
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of blood and serum markers in spinal cord injured patients with pressure sores.
Gurcay E; Bal A; Gurcay AG; Cakci A
Saudi Med J; 2009 Mar; 30(3):413-7. PubMed ID: 19271073
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis.
Burkhardt O; Derendorf H; Jäger D; Kumar V; Madabushi R; Röhl K; Barth J
Scand J Infect Dis; 2006; 38(10):904-8. PubMed ID: 17008236
[TBL] [Abstract][Full Text] [Related]
11. [Development of carcinoma in chronic pressure sores in patients with spinal cord injuries].
Ellitsgaard N; Hauge EN; Biering-Sørensen F
Ugeskr Laeger; 1993 May; 155(19):1473-4. PubMed ID: 8316976
[TBL] [Abstract][Full Text] [Related]
12. Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations.
Vaidyanathan S; Peloquin C; Wyndaele JJ; Buczynski AZ; Almog Y; Markantonis SL; Jayawardena V; Soni BM; Cannon J; Vidal J
ScientificWorldJournal; 2006 Feb; 6():187-99. PubMed ID: 16493523
[TBL] [Abstract][Full Text] [Related]
13. Amikacin pharmacokinetics in a patient with spinal cord injury.
McCue AB; Tan P
Clin Pharm; 1990 Mar; 9(3):163-4. PubMed ID: 2318021
[No Abstract] [Full Text] [Related]
14. Predictive Value of Braden Risk Factors in Pressure Ulcers of Outpatients With Spinal Cord Injury.
Sadeghi Fazel F; Derakhshanrad N; Yekaninejad MS; Vosoughi F; Derakhshanrad A; Saberi H
Acta Med Iran; 2018 Jan; 56(1):56-61. PubMed ID: 29436796
[TBL] [Abstract][Full Text] [Related]
15. [Thigh and leg musculo-cutaneous island flap for giant bilateral trochanteric and perineal pressure sores coverage: Extreme treatment in spinal cord injury].
André A; Crouzet C; De Boissezon X; Grolleau JL
Ann Chir Plast Esthet; 2015 Jun; 60(3):226-30. PubMed ID: 24503520
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the diverse factors concerned with the development of pressure sores in spinal cord injured patients.
Vidal J; Sarrias M
Paraplegia; 1991 May; 29(4):261-7. PubMed ID: 1870891
[TBL] [Abstract][Full Text] [Related]
17. Association between pressure sores and immobilization in the immediate post-injury period.
Linares HA; Mawson AR; Suarez E; Biundo JJ
Orthopedics; 1987 Apr; 10(4):571-3. PubMed ID: 3575181
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
[TBL] [Abstract][Full Text] [Related]
19. The perioperative management of the patient with pressure sores.
Stal S; Serure A; Donovan W; Spira M
Ann Plast Surg; 1983 Oct; 11(4):347-56. PubMed ID: 6638843
[TBL] [Abstract][Full Text] [Related]
20. Decreased systemic clearance of lorazepam in humans with spinal cord injury.
Segal JL; Brunnemann SR; Eltorai IM; Vulpe M
J Clin Pharmacol; 1991 Jul; 31(7):651-6. PubMed ID: 1894761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
